Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

350 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma.
Sacco JJ, Carvajal RD, Butler MO, Shoushtari AN, Hassel JC, Ikeguchi A, Hernandez-Aya L, Nathan P, Hamid O, Piulats JM, Rioth M, Johnson DB, Luke JJ, Espinosa E, Leyvraz S, Collins L, Holland C, Sato T. Sacco JJ, et al. Among authors: hassel jc. J Immunother Cancer. 2024 Jun 6;12(6):e009028. doi: 10.1136/jitc-2024-009028. J Immunother Cancer. 2024. PMID: 38844408 Free article. Clinical Trial.
[Side effects of oncologic therapies].
Zimmer L, Hassel JC. Zimmer L, et al. Among authors: hassel jc. Dermatologie (Heidelb). 2024 Jun;75(6):437-439. doi: 10.1007/s00105-024-05356-1. Epub 2024 Jun 4. Dermatologie (Heidelb). 2024. PMID: 38832994 German. No abstract available.
[Side effects of dermato-oncologic therapies].
Hassel JC, Zimmer L. Hassel JC, et al. Dermatologie (Heidelb). 2024 Jun;75(6):466-475. doi: 10.1007/s00105-024-05354-3. Epub 2024 May 27. Dermatologie (Heidelb). 2024. PMID: 38802653 Review. German.
First-line avelumab treatment in patients with metastatic Merkel cell carcinoma: 4-year follow-up from part B of the JAVELIN Merkel 200 study.
D'Angelo SP, Lebbé C, Mortier L, Brohl AS, Fazio N, Grob JJ, Prinzi N, Hanna GJ, Hassel JC, Kiecker F, von Heydebreck A, Güzel G, Nghiem P. D'Angelo SP, et al. Among authors: hassel jc. ESMO Open. 2024 May;9(5):103461. doi: 10.1016/j.esmoop.2024.103461. Epub 2024 May 13. ESMO Open. 2024. PMID: 38744102 Free PMC article. Clinical Trial.
Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors' perspective.
Kähler KC, Gutzmer R, Angela Y, Livingstone E, Lodde G, Meiss F, Rafei-Shamsabadi DA, Weyer-Fahlbusch SS, Nashan D, Loquai C, Hassel JC, Sachse MMM, Maul LV, Heinzerling L, Heppt MV, Colapietro C, Rusch J, Blome C. Kähler KC, et al. Among authors: hassel jc. J Cancer Res Clin Oncol. 2024 May 14;150(5):252. doi: 10.1007/s00432-024-05713-6. J Cancer Res Clin Oncol. 2024. PMID: 38743104 Free PMC article.
An Online Decision Aid for Patients With Metastatic Melanoma—Results of the Randomized Controlled Trial "PEF-Immun".
Grabbe P, Borchers MS, Gschwendtner KM, Strobel S, Wild B, Kirchner M, Kälber K, Rendon A, Steininger J, Meier F, Hassel JC, Bieber C. Grabbe P, et al. Among authors: hassel jc. Dtsch Arztebl Int. 2024 Jun 14;(Forthcoming):arztebl.m2024.053. doi: 10.3238/arztebl.m2024.053. Online ahead of print. Dtsch Arztebl Int. 2024. PMID: 38566437 Clinical Trial.
350 results